Odenthal, Germany

Klaus Grobe

This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Klaus Grobe. Retrieved from https://idiyas.com/inventor/klaus-grobe-xqki4mlh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Klaus Grobe

Introduction

Klaus Grobe, an esteemed inventor based in Odenthal, Germany, has made significant contributions to the field of pharmaceuticals. With a focus on antibacterial agents, his innovative spirit is reflected in his patented work that seeks to address critical health challenges.

Latest Patents

Klaus Grobe holds a patent for 8-chloro-1-cyclopropyl-6,7-difluoro-1, which pertains to the class of compounds known as 7-amino-1-cyclopropyl-6,8-dihalogeno-1,4-dihydro-4-oxo-3-quinoline-carboxylic acids. The invention details a process for producing these compounds and emphasizes their use in developing effective antibacterial agents.

Career Highlights

Klaus has dedicated his career to innovation in the pharmaceutical industry, working at Bayer Aktiengesellschaft, a prominent global company. His work focuses on creating new solutions that tackle bacterial infections, showcasing his commitment to improving public health.

Collaborations

In his quest for innovation, Klaus Grobe collaborates with talented professionals such as Uwe Petersen and Hans-Joachim Zeiler. This teamwork fosters a dynamic environment for research and development, leading to breakthroughs that benefit the medical community.

Conclusion

Klaus Grobe is a noteworthy inventor whose work has the potential to impact health outcomes significantly. His patent, alongside his collaborations at Bayer Aktiengesellschaft, marks him as a key player in the field of pharmaceuticals, particularly in the development of antibacterial agents. His contributions continue to inspire future innovations in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…